CGEN
Compugen Ltd.
NASDAQHealthcareBiotechnologyIL
Rating:A-
Company Profile
CEO
Eran Ophir
IPO Date
2000-08-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Compugen Ltd.
CEO
Eran Ophir
IPO Date
2000-08-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
| 1,875 |
| $2.50 |
| 13 Jul 2026 | Levine Zurit | SVP, Business Development | M-Exempt | Disposed | 1,875 | $0.83 |
| 27 Apr 2026 | Levine Zurit | SVP, Business Development | M-Exempt | Acquired | 2,000 | $1.15 |
| 27 Apr 2026 | Levine Zurit | SVP, Business Development | S-Sale | Disposed | 2,000 | $3.20 |
| 27 Apr 2026 | Levine Zurit | SVP, Business Development | M-Exempt | Disposed | 2,000 | $1.15 |
| 27 Apr 2026 | Ophir Eran | director, officer: President and CEO | M-Exempt | Acquired | 5,000 | $0.83 |
| 27 Apr 2026 | Ophir Eran | director, officer: President and CEO | S-Sale | Disposed | 5,000 | $3.20 |
| 27 Apr 2026 | Ophir Eran | director, officer: President and CEO | M-Exempt | Disposed | 5,000 | $0.83 |
| 15 Apr 2026 | Ophir Eran | director, officer: President and CEO | M-Exempt | Acquired | 5,000 | $0.83 |